Private company

Barinthus Biotherapeutics plc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersX0
  • Incorporated inUnited Kingdom2
  • Business address20400 Century Blvd, Suite 210, Germantown, Md 208742
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-100.0%Revenue growth, 20253
-89.5%Return on equity3
-$48.0MFree cash flow3

Financial statements

Revenue45673$0 in 2025
0$20.0M$40.0M$60.0M2020: $4.8M$4.8M20202021: $268.0K$268.0K2021−94%2022: $44.7M$44.7M2022+16580%2023: $802.0K$802.0K2023−98%2024: $15.0M$15.0M2024+1766%2025: $0$02025
Operating income45673-$70.6M in 2025+252% since 2020
-$100.0M-$75.0M-$50.0M-$25.0M02020: -$20.0M-$20.0M20202021: -$45.2M-$45.2M2021+126%2022: -$4.0M-$4.0M2022−91%2023: -$83.9M-$83.9M2023+1977%2024: -$68.0M-$68.0M2024−19%2025: -$70.6M-$70.6M2025+4%
Net income45673-$66.4M in 2025+275% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M0$20.0M2020: -$17.7M-$17.7M20202021: -$50.9M-$50.9M2021+187%2022: $5.3M$5.3M20222023: -$73.3M-$73.3M20232024: -$61.1M-$61.1M2024−17%2025: -$66.4M-$66.4M2025+9%
Fiscal year2019202020212022202320242025
Revenue$4.8M4$268.0K5$44.7M6$802.0K7$15.0M3$03
Research and development$14.4M4$20.4M5$42.4M6$44.9M7$42.2M3$25.6M3
Operating income-$20.0M4-$45.2M5-$4.0M6-$83.9M7-$68.0M3-$70.6M3
Interest$3.6M4$2.7M5$19.0K6$28.0K6
Income tax$95.0K4-$28.0K5-$4.5M6-$3.1M7-$44.0K3-$175.0K3
Net income-$17.7M4-$50.9M5$5.3M6-$73.3M7-$61.1M3-$66.4M3
Earnings per share-$2.244-$1.965$0.146-$1.917-$1.553-$1.643
Earnings per share (diluted)-$2.244-$1.965$0.146-$1.917-$1.553-$1.643

Compare Barinthus Biotherapeutics plc. with another company

Former names

  • Vaccitech plcJan 19, 2021 to Oct 5, 20232
  • Vaccitech LtdDec 23, 2020 to Mar 23, 20212

Recent filings

  1. Sep 11, 20264/A PRIMARY DOCUMENT
  2. Sep 9, 20268-K
  3. Sep 9, 20264 OWNERSHIP DOCUMENT
  4. Sep 9, 20264 OWNERSHIP DOCUMENT
  5. Sep 9, 20264 OWNERSHIP DOCUMENT
  6. Sep 9, 20264 OWNERSHIP DOCUMENT
  7. Sep 9, 20264 OWNERSHIP DOCUMENT
  8. Sep 9, 20264 OWNERSHIP DOCUMENT
  9. Sep 9, 20264 OWNERSHIP DOCUMENT
  10. Sep 9, 20264 OWNERSHIP DOCUMENT
  11. Sep 1, 20268-K
  12. Aug 25, 20268-K
  13. Aug 6, 202610-Q
  14. Aug 6, 20268-K
  15. Jul 2, 20268-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1